Keith A. Johnson

Active 1986–2025

Also published as
Keith A Johnson
306
Papers
47,729
Citations
115
h-index
289
i10-index

Citations

Citations per year for Keith A. Johnson1949: 1 citations1957: 1 citations1988: 2 citations1989: 2 citations1990: 2 citations1991: 7 citations1992: 6 citations1993: 7 citations1994: 12 citations1995: 21 citations1996: 28 citations1997: 36 citations1998: 47 citations1999: 37 citations2000: 54 citations2001: 61 citations2002: 58 citations2003: 57 citations2004: 62 citations2005: 57 citations2006: 37 citations2007: 53 citations2008: 76 citations2009: 145 citations2010: 191 citations2011: 367 citations2012: 349 citations2013: 458 citations2014: 518 citations2015: 557 citations2016: 683 citations2017: 847 citations2018: 889 citations2019: 2,061 citations2020: 2,327 citations2021: 2,334 citations2022: 2,038 citations2023: 1,772 citations2024: 2,737 citations2025: 1,784 citations2026: 85 citations1950–1956: no citations, so these years are not shown1958–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,975 citing papers, 29.5% of this breakdownUnited Kingdom: 2,060 citing papers, 8.7% of this breakdownChina: 1,669 citing papers, 7.1% of this breakdownGermany: 1,320 citing papers, 5.6% of this breakdownCanada: 1,048 citing papers, 4.4% of this breakdownSweden: 1,020 citing papers, 4.3% of this breakdownNetherlands: 906 citing papers, 3.8% of this breakdownAustralia: 813 citing papers, 3.4% of this breakdownSpain: 789 citing papers, 3.3% of this breakdownItaly: 783 citing papers, 3.3% of this breakdownFrance: 762 citing papers, 3.2% of this breakdownSwitzerland: 559 citing papers, 2.4% of this breakdown
0%29.5%Other 21%

Fields

  • Medicine58.7%
  • Neuroscience26.7%
  • Biochemistry, Genetics and Molecular Biology5.8%
  • Computer Science2%
  • Psychology1.7%
  • Agricultural and Biological Sciences1.3%
  • Other3.8%

Topics

  • Alzheimer's disease research and treatments14.5%
  • Dementia and Cognitive Impairment Research13.6%
  • Functional Brain Connectivity Studies7.5%
  • Advanced Neuroimaging Techniques and Applications2.8%
  • Neuroinflammation and Neurodegeneration Mechanisms2.4%
  • Neural dynamics and brain function2.2%
  • Other57%

Coauthors

All papers

Open in search
  1. The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET

    Authors: , , , , , , , , , , , , - Alzheimer s & Dementia 2014 cited by 1,326

  2. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

    Authors: , , , , , , , , , , , , , - Neurology 2016 cited by 1,880

  3. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 cited by 482

  4. Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2019 cited by 872

  5. Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pradeep Thiyyagura, Yi Su, Gyungah Jun, Marcus Naymik, Xiaowu Gai, Moiz Bootwalla, Jianling Ji, Li Shen, John B. Miller, Leo A. Kim, Pierre N. Tariot, Keith A. Johnson, Eric M. Reiman, Yakeel T. Quiroz - Nature Medicine 2019 cited by 605

  6. The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2022 cited by 264

  7. Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease

    Authors: , , , , , , , , - Journal of Neuroscience 2009 cited by 2,949

  8. PET image denoising based on denoising diffusion probabilistic model

    Authors: , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2023 cited by 143

  9. Tau positron emission tomographic imaging in aging and early A lzheimer disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Annals of Neurology 2015 cited by 1,008

  10. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ann D. Cohen, Alisha Daniels, Marion Delarue, Mira Didic, Alexander Drzezga, Bruno Dubois, Marie Eckerström, Laura L. Ekblad, Sebastiaan Engelborghs, Stéphane Epelbaum, Anne M. Fagan, Yong Fan, Tormod Fladby, Adam Fleisher, Wiesje M. van der Flier, Stefan Förster, Juan Fortea, Kristian Steen Frederiksen, Yvonne Freund‐Levi, Lars Frings, Giovanni B. Frisoni, Lutz Fröhlich, Tomasz Gabryelewicz, Hermann‐Josef Gertz, Kiran Dip Gill, Olymbia Gkatzima, Estrella Gómez‐Tortosa, Timo Grimmer, Eric Guedj, Christian Habeck, Harald Hampel, Ron Handels, Oskar Hansson, Lucrezia Hausner, Sabine Hellwig, Michael T. Heneka, Sanna‐Kaisa Herukka, Helmut Hildebrandt, John R. Hodges, Jakub Hort, Chin‐Chang Huang, Ane Iriondo, Yoshiaki Itoh, Adrian Ivanoiu, William J. Jagust, Frank Jessen, Peter Johannsen, Keith A. Johnson, Ramesh Kandimalla, Elisabeth Kapaki, Silke Kern, Lena Kilander, Aleksandra Klimkowicz‐Mrowiec, William E. Klunk, Norman Koglin, Johannes Kornhuber, Milica G. Kramberger, Hung‐Chou Kuo, Koen Van Laere, Susan Landau, Brigitte Landeau, Dong Young Lee, Mony J. de Leon, Cristian E. Leyton, Kun‐Ju Lin, Alberto Lleó, Malin Löwenmark, Karine Madsen, Wolfgang Maier, Jan Marcusson and 83 more - JAMA Neurology 2022 cited by 288

  11. Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2023 cited by 145

  12. Brain Imaging in Alzheimer Disease

    Authors: , , , - Cold Spring Harbor Perspectives in Medicine 2012 cited by 861

  13. Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jianling Ji, Li Shen, Kenneth S. Kosik, Yi Su, Yinghua Chen, Aaron P. Schultz, Reisa A. Sperling, Keith A. Johnson, Eric M. Reiman, Diego Sepúlveda‐Falla, Joseph F. Arboleda‐Velásquez, Yakeel T. Quiroz - Nature Medicine 2023 cited by 189

  14. Association of Age at Menopause and Hormone Therapy Use With Tau and β-Amyloid Positron Emission Tomography

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2023 cited by 123

  15. Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals

    Authors: , , , , , , , , , - JAMA Neurology 2020 cited by 329

  16. The impact of amyloid‐beta and tau on prospective cognitive decline in older individuals

    Authors: , , , , , , , , , , , , , , , , , , , , , - Annals of Neurology 2018 cited by 288

  17. The cortical origin and initial spread of medial temporal tauopathy in Alzheimer’s disease assessed with positron emission tomography

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2021 cited by 207

  18. Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cynthia Picard, David Maillet, Diane Michaud, Doris Couture, Doris Dea, A. Claudio Cuello, Alan Barkun, Alan C. Evans, Blandine Courcot, Christine Tardif, Clément Debacker, Clifford R. Jack, David Fontaine, David S. Knopman, Gerhard Multhaup, Jamie Near, Jeannie‐Marie Leoutsakos, Jean‐Robert Maltais, Jason Brandt, Jens C. Pruessner, John C. Morris, John C.S. Breitner, Judes Poirier, Laksanun Cheewakriengkrai, Lisa-Marie MÃ ⁄ nter, D. Louis Collins, M. Mallar Chakravarty, Mark A. Sager, Marina Dauar‐Tedeschi, Mark J. Eisenberg, Natasha Rajah, Paul Aisen, Paule‐Joanne Toussaint, Pedro Rosa‐Neto, Pierre Bellec, Penelope Kostopoulos, Pierre Étienne, Pierre N. Tariot, Pierre Orban, Reisa A. Sperling, Rick Hoge, Ronald G. Thomas, Serge Gauthier, Suzanne Craft, Sylvia Villeneuve, Thomas J. Montine, Vasavan Nair, Véronique D. Bohbot, Vinod Venugopalan, Vladimir Fonov, Yasser Ituria‐Medina, Zaven S. Khachaturian, Eduard Teigner, Elena Anthal, Elsa Yu, Fabiola Ferdinand, Galina Pogossova, Ginette Mayrand, Guerda Duclair, Guylaine Gagné, Holly Newbold‐Fox, Illana Leppert, Isabelle Vallée, Jacob W. Vogel, Jennifer Tremblay‐Mercier, Joanne Frenette, Josée Frappier, Justin Kat, Justin Miron, Karen Wan and 99 more - JAMA Neurology 2022 cited by 133

  19. In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer’s disease pathology and cognitive decline

    Authors: , , , , , , , , , , , , , , , , - Science Translational Medicine 2021 cited by 240

  20. The A4 Study: Stopping AD Before Symptoms Begin?

    Authors: , , , , , , - Science Translational Medicine 2014 cited by 771

  21. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2019 cited by 373

  22. The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials

    Authors: , , - Neuron 2014 cited by 735

  23. Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2022 cited by 89

  24. Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

    Authors: , , , , , , , , , , , , - Alzheimer s & Dementia 2013 cited by 596